載入...
Scutellarin Increases Cisplatin-Induced Apoptosis and Autophagy to Overcome Cisplatin Resistance in Non-small Cell Lung Cancer via ERK/p53 and c-met/AKT Signaling Pathways
Cisplatin, as the first-line anti-tumor agent, is widely used for treatment of a variety of malignancies including non-small cell lung cancer (NSCLC). However, the acquired resistance has been a major obstacle for the clinical application. Scutellarin is a active flavone extracted from Erigeron brev...
Na minha lista:
| 發表在: | Front Pharmacol |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5816782/ https://ncbi.nlm.nih.gov/pubmed/29487530 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.00092 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|